SMYD3 and cancer: Although there is a small molecule SMYD3 inhibitor that is considered to have good bioavailability,18 or others can inhibit cancer cell proliferation,19, 20 currently, no molecules targeting SMYD3 have been reported to be used in clinical cancer treatment.